Merck Buys Bio-Techne
Merck agrees to buy Bio-Techne for $73 per share in cash, valuing the company at an enterprise value of $11.3 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Merck Buys Bio-Techne
Merck KGaA agrees to acquire Bio-Techne Corporation in an all-cash transaction valued at approximately $11.3 billion
Merck Buys Bio-Techne
Merck agrees to buy Bio-Techne for $73 per share in cash, valuing the company at an enterprise value of $11.3 billion.